Bonus Biogroup Stock Shares Outstanding
| BBIXF Stock | USD 0.02 0.00 0.00% |
Bonus BioGroup fundamentals help investors to digest information that contributes to Bonus BioGroup's financial success or failures. It also enables traders to predict the movement of Bonus Pink Sheet. The fundamental analysis module provides a way to measure Bonus BioGroup's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bonus BioGroup pink sheet.
Bonus |
Bonus BioGroup Company Shares Outstanding Analysis
Bonus BioGroup's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bonus BioGroup Shares Outstanding | 1.17 B |
Most of Bonus BioGroup's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bonus BioGroup is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Bonus BioGroup has 1.17 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 104.25% lower than that of the firm.
Bonus Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bonus BioGroup's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bonus BioGroup could also be used in its relative valuation, which is a method of valuing Bonus BioGroup by comparing valuation metrics of similar companies.Bonus BioGroup is currently under evaluation in shares outstanding category among its peers.
Bonus Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.0636 | |||
| Current Valuation | 48.99 M | |||
| Shares Outstanding | 1.17 B | |||
| Shares Owned By Insiders | 49.72 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 4.05 X | |||
| EBITDA | (88.03 M) | |||
| Net Income | (90.08 M) | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 9.13 X | |||
| Cash Flow From Operations | (39.84 M) | |||
| Beta | 1.4 | |||
| Market Capitalization | 62.59 M | |||
| Total Asset | 104.32 M | |||
| Net Asset | 104.32 M |
About Bonus BioGroup Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bonus BioGroup's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bonus BioGroup using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bonus BioGroup based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bonus Pink Sheet
Bonus BioGroup financial ratios help investors to determine whether Bonus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus BioGroup security.